Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Prevention of Surgical Site Infections
This study is currently recruiting participants.
Verified by The University of Texas Health Science Center, Houston, November 2008
Sponsors and Collaborators: The University of Texas Health Science Center, Houston
Robert Wood Johnson Foundation
Information provided by: The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier: NCT00353613
  Purpose

The primary research question is whether interventions to prevent caregiver and system errors will increase the proportion of laparotomy patients who receive recommended measures to prevent surgical site infections.


Condition Intervention
Surgical Wound Infection
Behavioral: Package of targeted interventions to reduce error

Drug Information available for: Dextrose
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Non-Randomized, Open Label, Uncontrolled, Parallel Assignment, Efficacy Study
Official Title: Prevention of Surgical Site Infections

Further study details as provided by The University of Texas Health Science Center, Houston:

Primary Outcome Measures:
  • Proportion of laparotomy patients receiving recommended measures to prevent surgical site infections [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Surgical site infections [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 900
Study Start Date: March 2007
Estimated Study Completion Date: June 2009
Estimated Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1
LBJ Hospital
Behavioral: Package of targeted interventions to reduce error
Interventions will include changes in administration of antibiotics and the improved monitoring of blood glucose and body temperature peri-operatively.
2
Ben Taub Hospital
Behavioral: Package of targeted interventions to reduce error
Interventions will include changes in administration of antibiotics and the improved monitoring of blood glucose and body temperature peri-operatively.

Detailed Description:

Background: Surgical site infections (SSIs) cause significant and largely preventable morbidity, mortality, and resource use due to failure to comply with evidence-based guidelines. Quality improvement programs report increased compliance with these guidelines, but are subject to a variety of biases.

Hypothesis: The primary hypothesis is that a targeted intervention program will increase the proportion of patients in a county hospital who receive recommended interventions to prevent SSIs, when assessed in the most rigorous feasible clinical trial. The specific aims of the trial are to establish practical surveillance measures to determine the percentage of patients whose care complies with 5 major guidelines to prevent SSIs; to use chart review, direct observation, attitude surveys, and focus groups to identify, quantify, and address latent and active errors linked to non-compliance, and to develop, implement, and assess the effectiveness of an intervention program to increase guideline compliance.

Study Design: An innovative trial design will be performed with 3 staggered phases in the two major county hospitals in Houston, TX. This design allows for adjustment for temporal trends and hospital differences in assessing the intervention program in a large, high-risk, disadvantaged urban population. Based on a compliance goal of 95%, this design has adequate power to detect even a small absolute increase ( >= 5%) above baseline in the percentage of patients receiving all 5 recommended preventive measures.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All patients undergoing laparotomy at either Ben Taub Hospital or Lyndon Baines Johnson Hospital in Houston, Texas

Exclusion Criteria:

  • None
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00353613

Contacts
Contact: Lillian S Kao, MD 713-566-5095 Lillian.S.Kao@uth.tmc.edu
Contact: Kevin P Lally, MD 713-500-7300 Kevin.P.Lally@uth.tmc.edu

Locations
United States, Texas
Lyndon Baines Johnson General Hospital Recruiting
Houston, Texas, United States, 77026
Contact: Lillian S Kao, MD     713-566-5095     Lillian.S.Kao@uth.tmc.edu    
Contact: Debbie F Lew, MPH, CCRC     713-500-6886     Debbie.F.Lew@uth.tmc.edu    
Principal Investigator: Lillian S Kao, MD            
Ben Taub General Hospital Not yet recruiting
Houston, Texas, United States, 77030
Contact: Kathleen R Liscum, MD         liscum@bcm.tmc.edu    
Contact: Matthew Carrick, MD         mcarrick@bcm.tmc.edu    
Sub-Investigator: Kathleen R Liscum, MD            
Sub-Investigator: Matthew Carrick, MD            
Sponsors and Collaborators
The University of Texas Health Science Center, Houston
Robert Wood Johnson Foundation
Investigators
Principal Investigator: Lillian S Kao, MD The University of Texas Health Science Center, Houston
  More Information

Robert Wood Johnson Physician Faculty Scholars bio page  This link exits the ClinicalTrials.gov site

Responsible Party: UT Health Science Center at Houston ( Lillian S. Kao, MD, Associate Professor )
Study ID Numbers: HSC-MS-050570, RWJ ID#57405
Study First Received: July 17, 2006
Last Updated: November 6, 2008
ClinicalTrials.gov Identifier: NCT00353613  
Health Authority: United States: Institutional Review Board

Keywords provided by The University of Texas Health Science Center, Houston:
Antibiotic prophylaxis

Study placed in the following topic categories:
Postoperative Complications
Wounds and Injuries
Disorders of Environmental Origin
Surgical Wound Infection
Wound Infection

Additional relevant MeSH terms:
Communicable Diseases
Pathologic Processes
Infection

ClinicalTrials.gov processed this record on January 14, 2009